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During the well-established reaction pathways of nitrosoarenes interacting with thiols, a reactive N-(thiol-S-yl)-arylamine cation was implicated in the
so-called rearrangement reaction which transforms the semimercaptal to the sulfinamide. In the case of nitrosoarenes with i-donating substituents,
this cationic transition state includes resonance structures bearing the positive charge in 2 and 4 position, thereby facilitating the attack of nucleo-
philes to the aromatic ring. Investigating the reaction products of 4-nitrosophenetol and reduced glutathione in chemical systems and human red
cells, some glutathione S-conjugates were detected other than the already known sulfenamide and sulfinamide. Three of them were separated by
HPLC and identified by mass spectroscopy, 1H-NMR, and UV-visible spectroscopy, by determination of PKa values and chemical behavior. The hitherto
unknown conjugates are 4-ethoxy-2-(glutathione-S-yl)-aniline, N-(4-ethoxyphenyl)-N'-(glutathione-S-yIl)-benzoquinonediimine, and 4-amino-4'-ethoxy-
2-(glutathione-S-yl)-diphenylamine. In preliminary experiments, some of these conjugates were shown to be highly active in producing ferrihemoglo-
bin. Considerations on the formation pathways of these metabolites lend further support to the electrophilic N-(glutathione-S-yl)arylamine cation as a
reactive intermediate that may be implicated in nitrosoarene toxicity. - Environ Health Perspect 102(Suppl 6):137-142 (1994)
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Introduction
Reactions ofnitrosoarenes with cellular thiols
are gaining increasing toxicologic interest
(1). During the well-established reaction
pathways leading to N-hydroxyarylamines,
sulfinamides, and sulfenamides (2-4), reac-
tive intermediates are formed, such as
phenylnitroxide free radicals (5) and the
metastable semimercaptals (6-8). Recently,
an intermediate N-(thiol-S-yl)-arylamine
cation was implicated during the so-called
rearrangement reaction which transforms
the semimercaptal to the sulfinamide (7,9).
In the case of nitrosoarenes with i-donat-
ing substituents, this cationic transition
state includes resonance structures bearing
the positive charge in 2 and 4 position,
thereby facilitating the attack of nucleo-
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philes to the aromatic ring (7). During the
reaction of4-nitrosophenetol (NOPt) with
reduced glutathione (GSH) in chemical
systems and human red cells, hitherto
unknown glutathione S-conjugates were
detected which confirm the intermediate
occurrence of the electrophilic N-(glu-
tathione-S-yl)-arylamine cation.
Materials and Methods
NOPt (10) (containing 0.7% 4-nitro-
phenetol), [u-ring- 4C]-NOPt (11) (18.7
KBq/pmoles; containing 2% 4-nitrophene-
tol, 2% azoxyphenetol, and 0.4% 4-
ethoxy-4'-nitrosodiphenylamine),
N-(glutathione-S-yl)-4-phenetidine (4)
(sulfenamide), and 4-ethoxy-4'-nitrosodi-
phenylamine (12) were prepared as
described previously. 4-Amino-4'-ethoxy-
diphenylamine (11) (NH2EDPA) was
obtained by reduction of 4-ethoxy-4'-
nitrosodiphenylamine in CH3CN with 5-
fold excess ascorbate under sonication for 2
min. All other reagents were from commer-
cial sources at the purest grade available.
Syntheses:
4-Ethoxy-2-(glutathione-S-yl)-aniline.
GSH (0.25 mmole: 100 mM dissolved in
phosphate buffer, pH 7.0) was mixed with
NOPt (0.025 mmole: 1 M in MeOH) and
allowed to react for about 5 min at 20°C
(raw yield: 11% oftheory, as detected with
[u-ring- C]-NOPt). Lipophilic metabo-
lites were removed by ether extraction (5 x
1 vol), hydrophilic ones by semipreparative
HPLC. The colorless compound was stable
as solid and in aqueous solutions for
months.
4-Amino-4'-ehoxy-2-gltaine-S-yl)-
diphenylamine. NH2EDPA (24 pmoles: 9
mM in MeOH/ phosphate buffer, pH 7.4
[vol/vol]) was oxidized with PbO2 (0.5
mmole) during 1 min sonication. LC-MS
analysis ofthe supernatant showed a mole-
cular ion being 2 mu smaller than
NH2EDPA, indicating the formation ofN-
(4-ethoxyphenyl)-4-benzoquinone diimine.
The orange solution discolored within 1
min upon addition of GSH (125 pmoles:
0.5 M in phosphate buffer, 0.2 M, pH
7.4). The product was purified by semi-
preparative HPLC (yield: 12.2 pmoles,
52% oftheory).
N-(4-Ethox'yphenyl)-N'-(glutathione-
S-yl)-4-benzoquinone diimine. 4-Ethoxy-
4'-nitrosodiphenylamine (0.1 mmole in 50
ml MeOH and 40 ml ammonium carbon-
ate buffer, 0.1 M, pH 10) was mixed quickly
with GSH (0.1 mmole in 10 ml ammonium
carbonate buffer) and allowed to react for
about 5 min at 20°C. Excess educt and the
reduction product NH2EDPAwere removed
by ether extraction (4 x 1 vol). The red-
brown product was chromatographically
pure (yield: 77 pmoles, 77% oftheory).
The corresponding ,-mercaptoethanol
and t-butylmercaptan derivatives were syn-
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thesized similarly at pH 11. t-Butylmer-
captan reacted only during refluxing at
100°C for 17 hr. The products were purified
by thin-layer chromatography on silica gel
plates 60-F254, 0.25 mm thickness from E.
Merck (Darmstadt, Germany), using chlo-
roform/hexan mixtures as mobile phase.
'H-NMR spectra were recorded with
an AM-400 MHz or an AM-500 MHz
instrument from Bruker (Rheinstetten-
Forchheim, Germany) with H20 set to
4.80 ppm. Electron impact mass spectra
(EI-MS) and fast atom bombardment-
mass spectra (FAB-MS) were recorded with
T I , I I
j iA
0 3 6 9 12 15
tEmin]
0 3 6 9 12 15
t[min]
Figure 1. HPLC separation of hydrophilic metabolites
of 4-nitrosophenetol after reaction with GSH. [u-ring-
14C]-NOPt (5 mM) was added to GSH (in sodium phos-
phate buffer, 0.2 M, pH 7.4) and incubated for 0.5 hr at
37°C. Lipophilic products were removed by ether
extraction. Samples were separated by HPLC on
Novapak C18 with MeOH/sodium phosphate buffer (pH
7) gradient, detection at 220 to 320 nm (for structure
see Figure 2). (A) 25 mM GSH; the hydrophilic metabo-
lites amounted to 15% of total activity. (B) 1 mM GSH;
the hydrophilic metabolites amounted to 5% of total
activity. See Table 1 for abbreviations.
a CH-7A instrument from Varian or a
MAT 312 instrument, respectively, each
coupled with a data system SS 200 MS
from Finnigan MAT (Bremen, Germany).
Liquid chromatography mass spectra (LC-
MS) were prepared with a thermospray
LC-MS HP 5988a coupled with an HP
1050 HPLC system from Hewlett Packard
(Bad Homburg, Germany) on Lichrosorb
100 RP 18 (125 mm x 4.6 mm i.d., Merck)
and isocratic elution with 60% MeOH/
40% ammonium acetate buffer (0.08 M,
pH 7.4). HPLC was performed with a gra-
dient system consisting of a low pressure
gradient former L 6200 from Merck-
Hitachi (Darmstadt, Germany), a UV-visible
diode-array detector SPDM6A from
Shimadzu (Egling, Germany), coupled
with a personal computer 8810 M 45 from
Nixdorf (Munchen, Germany) and a NEC
P7-plus pinwriter (Munchen, Germany).
Analytical separations were carried out on
Novapak C18 (15 cm x 4 mm i.d.; Waters,
Milford, MA) with MeOH/sodium phos-
phate buffer (10 mM, pH 7) gradients and
detection, if not otherwise stated, at two
wavelength windows (230-250 nm and
300-400 nm); for semipreparative separa-
tions, p-Bondapak C18 columns (30 cm x
8 mm i.d., Waters) and MeOH/ammonium
hydrogencarbonate buffer (10 mM, pH 7)
gradients were used. Peaks were identified
by comparing the UV-visible spectra
(220-600 nm) and retention times with
that of authentic compounds. pKA values
were determined by spectroscopic titration.
Primary aromatic amino groups were
detected by their reaction with Echtblausalz
B (13). Radioactivity was measured in
Bray's solution (14) with a LKB Rackbeta
1217 liquid scintillation counter.
Human hemoglobin was obtained from
outdated blood and purified by column
chromatography as described (15). The fer-
rihemoglobin content was less than 5%
throughout. Free SH groups (,B93 Cys)
were alkylated with N-ethylmaleimide (16)
and excess reagent removed by dialysis
against phosphate buffer. Experiments on
ferrihemoglobin formation by NOPt
metabolites were carried out in sodium
phosphate buffer (0.2 M, pH 7.4) at 37°C
under free access of air. The volumes of
added metabolite solutions were less than
3% throughout. Hemoglobin, ferrihemo-
globin, and glutathione were determined as
described previously (10).
Results and Discussion
During the HPLC separation of NOPt/
GSH incubates, some hydrophilic metabo-
lites were detected other than the already
known sulfenamide and sulfinamide
(Figure 1).
4-Ethoxcy-2-(glutathione-S-yl)-aniline
This compound was obtained in optimized
yield from incubates ofNOPt with 10-fold
excess GSH (pH 7.0, 20°C). Positive reac-
tions with Echtblausalz B and with ninhy-
drin indicated a primary aromatic amine
containing a glutathione residue. Its FAB'
mass spectrum showed the molecular ion at
m/z = 443 (M+1) and main fragments at
m/z = 368 (M-Gly), 314 (M+2-Glu), and
168 (M-Glu-Ala-Gly), indicating a glu-
tathionyl substituted phenetidine. The
UV-visible spectrum (Table 1) differed dis-
tinctly from that of the sulfenamide N-
(glutathione-S-yl)-4-ethoxyaniline (6,9)
but agreed with that of 2-(thiol-S-yl)-4-
hydroxyaniline (17). The 1H-NMR spec-
trum showed aliphatic signals belonging to
the ethoxy group and the glutathionyl sub-
stituent and aromatic signals of three pro-
tons indicating a 1,2,4-substituted aromatic
Table 1.pKavalues and UV-visible data of some 4-nitrosophenetol metabolites.
Emax' -
Metabolite PKai/PKa2 Solvent nm mM cm
GS-NH2Pt 3.7 MeOH/Na-PO4(10mM, pH 6.5), 20/80(V/V) 236 10.4
314 3.8
NH2Pt 5.3 MeOH/Na-PO4 (0.2 M, pH 7.4), 20/80(V/V) 232 9.9
295 2.1
GS-NH2EDPA 5.2/<0 MeOH/Na-PO4 (10 mM, pH 7.0), 35/65(V/V) 246 13.1
289 12.3
NH2EDPA 5.4/0.3 MeOH/Na-PO4(10 mM, pH7.4), (VAV) 284 14.2
MeOH 287 17.3
GS-EPQDI 4.9 MeOH 412 21
Na-PO4(5mM, pH 7-11) 418 19.2
HCI(pH 1.8) 492 28
Abbreviations: GS-NH2Pt, 4-ethoxy-2-(glutathione-S-yI)-aniline; NH2Pt, 4-phenetiolin; GS-NH2EDPA, 4-amino-4'-
ethoxy-2-(glutathione-S-yl)-diphenylamine; NH2EDPA, 4-amino-4'-ethoxydiphenylamine; GS-EPQDI, N-(4-
ethoxyphenyl)-N'-(glutathione-S-yl)-4-benzoquinone diimine.
Environmental Health Perspectives
0.3
Uf)
LI-
.4
0
0.1 -' cr --r B
n E
0a
6. tn 2
I j 1 4~~~~~~0:
z w
0
U)
U-
0
.. ..
F-
138GLUTATHIONES-CONJUGATES OF4-NITROSOPHENETOL
ring. From the signal shifts in acidic solu-
tion it was derived that the ortho position
to the amino group is substituted by glu-
tathione (Table 2). This structure was
confirmed by the distinctly lower pKa of
GS-NH2Pt compared to the parent amine
NH2Pt (Table 1). [It has been shown pre-
viously that the pKa of primary aromatic
amino groups is considerably decreased by
ortho-substitution with thiols but hardly by
meta-substitution (17)].
4-Amino-4'-ethoxy-2-(glutathione-S-
yi)-diphenylamine
This metabolite from NOPt/GSH incu-
bates was obtained in much higher yields
when NH2EDPA was oxidized to the cor-
responding benzoquinone diimine and
added to GSH. Positive reactions with
Echtblausalz B and with ninhydrin pointed
to a primary arylamine substituted with
glutathione. The FAB' mass spectrum
revealed the molecular ion at m/z = 534
Table 2. 1H-NMR data of 4-ethoxy-2-(glutathione-S-yl)-aniline (GS-NH2Pt) and 4-phenetidine (NH2Pt) in neutral
(D20) and acidic solution (DCI, pD-1).
H, SG
CH3CH,O NH,
H, H,
CH3-
-CH20-3
( J)
Ha (3j
(4A)
Hc (J
Cys la
Cys )52
Cys a
Gly
Gluy
Glu)
Glu a
GU-NH2pt
1.47 <3,t>
(6.8)
4.21 <2,q>
(6.8)
7.21 <i,d>
(9.0)
7.07 <1,dd>
(9.0/2.6)
7.28<1,d>
(2.6)
3.37 <1>
3.44 <1>
4.62 <1>
3.76 <2>
2.55 <2>
2.19 <2>
3.84 <1>
6 [ppm]<rele intensity, signal> (J [Hz])
GS-NH-H P - NH Pt
1.46<3,t> 1.43 <3,t>
(6.6) (7.0)
4.22 <2,q> 4.14 <2,q>
(6.6) (7.0)
7.49 <1,d> 6.91 <2,d>
(8.0) (9.0)
7.14<1,d> 6.98 <2,d>
(8.0) (9.0)
7.38<1,d>
(NR)
so
so
4.69<1>
3.90 <2>
2.56 <2>
2.24 <2>
4.10 <1>
NH3:Pt
1.43<3,t>
(7.0)
4.17 <2,q>
(7.0)
7.15 <2,d>
(7.8)
7.06 <2,d>
(7.8)
Abbreviations: NR, not resolved; SO, signal overlapped with MeOH; d, duple; dd, double duple; t, triple, q, quarte.
aGlutathione protons were assigned according to Rabenstein et al. (18).
Table 3. 'H-NMR data of GS-NH2EDPA and NH2EDPA in neutral (D20) and acidic solution (DCI, pD--1).
GS H CH,CH,O52-NHG
H.
6[ppm]<rel intensity,signal> (J [Hz])
H, H, H, H, GS-NH2EDPA GS-NH3+EDPA NH3+EDPA
CH3- 1.46<3,t> 1.46 <3,t> 1.45 <3,t>
(3J) (6.6) (6.9) (6.9)
-CH20- 4.21 <2,q> 4.21 <2,q> 4.20 <2,q>
2(3J) (6.6) (6.9) (6.9)
Ha 7.22 <2,d> 7.25 <2,d> 7.26 <2,d>
(3J) (NR) (8.5) (8.1)
Hb 7.09 <2,d> 7.10 <2,d> 7.09 <2,d>
(3J) (8.0) (8.5) (8.1)
Hc 7.12<1,d> 7.15 <l,d> 7.18 <2,d>
(3J) (NR) (8.8) (8.0)
Hd 7.21 <1,d> 7.28 <1,d> 7.35<2,d>
(3J) (NR) (NR) (8.0)
H 7e53<1,s> 7.63 <is>
Cys 1 3.28 < 3.25 <'>
CysP2 3.47 <1> 3.47 <1>
Cysac 4.50 <2> 4.45<1'>
Gly 3.71 <2> 3.96 <2>
Glu y 2.51 <2> 2.52 <2>
Glu i 2.11 <2> 2.13 <2>
Glu a 3.76<1> 4.01 <'>
(M+1) and main fragments at m/z = 260
(M+l-Glu-Ala-Gly) and 228 (M+1-GS),
indicating a glutathione conjugate of
NH2EDPA. The IH-NMR spectrum
showed aliphatic signals belonging to the
ethoxy and the glutathionyl group; besides
the two proton pairs ofthe ethoxyring, the
aromatic signals indicated three single pro-
tons, ofwhich two were shifted to lower
field during acidification (Table 3).
Therefore, the position of the glutathione
substituent was assumed to be meta
referred to the primary amino group.
Accordingly, the pKal ofthis amino group
was only slightly decreased upon glu-
tathione substitution (Table 1). [A similar
compound has been proposed to occur
during the peroxidase-catalyzed oxidation
ofNH2Pt in the presence ofGSH (19)].
N-(4-Ethoxyphenyl)-N'-(glutathione-
S-yl)-4-benzoquinone diimine
The orange compound was immediately
formed at maximal yields in incubates of
NOPt with about 2.5-fold excess GSH
(pH 7.4, 200C); further GSH addition
resulted in discoloring. Interestingly, this
NOPt metabolite was obtained in nearly
quantitative yield during the reaction of4-
ethoxy-4'-nitrosodiphenylamine with
equivalent amounts of GSH at pH 10.
Identification of the glutathione derivative
by FAB' and El mass spectra was unsuc-
cessful as the compound discolored
instantly, probably by reduction. However,
the ,3-mercaptoethanol and t-butyl-
mercaptan derivatives revealed reasonable'
mass spectra (in a hardly reducing 3-nitro-
benzylalcohol matrix), indicating a benzo-
quinone diimine substituted with one
ethoxyphenyl and one thiol group (Table 4).
H-NMR spectra of the three derivatives
showed the aliphatic signals of the ethoxy
group and the respective thiol. The aromatic
protons (relative intensity: 7-8 protons),
however, revealed a highly complex splitting
pattern resulting from the signal overlap of
the ethoxyphenyl ring with two cis-trans-
isomeric forms ofthe quinone diimine ring
(J Sonnenbichler, personal communica-
tion, 1992).
In order to clarify the position of the
glutathionyl substitution in this metabolite,
some chemical experiments were undertaken.
Reduction ofN-(4-ethoxyphenyl)-N'-(glu-
tathione-S-yl)-4-benzoquinone diimine
(GS-EPQDI) with GSH delivered 4-
amino-4'-ethoxy-2-(glutathione-S-yl)-
diphenylamine (GS-NH2EDPA) as one of
the products, indicating that GS-EPQDI
may be the corresponding benzoquinone
diimine of GS-NH2EDPA. However,
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Table 4. Fast atom bombardment and electron impact mass spectra ofthe glutathione-, 1-mercaptoethanol-, and
t-butylmercaptan-derivatives of V-(4-ethoxyphenyl)-N'-(thiol-S-yl)-4-benzoquinonediimine.
R=Glu-Ala-Gly R=-CH2CH20H R=-C(CH3)3 C2His
O 9gR (m=274) (m=45) (m=57) 45 135 257 FAB+_MS El-MS FAB+-MS FAB+-MS El-MS
fragment (glycerol) (3-nitrobenzylalcohol) (3-nitrobenzylalcohol)
[MI+ 302 (15%) 314 (10%) 314 (57%)
[M+1]+ 303 (29%) 315 (35%) 315 (12%)
[M+2]+ 533 (6%) 304 (11%) 316 (24%) 316 (5%)
[M+3]+ 534 (15%) 305 (4%) 317 (6%)
258 (6%)
227 (23%)
228 (54%)
229 (59%)
227 (3%)
228 (86%)
229 (12%)
197 (5%)
199 (100%)
200 (24%)
227 (14%)
257 (5%)
258 (10%) 258 (100%)
259 (38%) 259 (17%)
260 (6%)
228 (11%)
229 (65%)
230 (26%)
225 (6%)
227 (24%) 227 (2%)
228 (12%)
197 (22%)
199 (11%)
[M+1-C6H4NS§R( 136 (24%) 136 (55%)
[RI+ 57 (100%) 57 (27%)
Abbreviations: FAB+-MS, fast atom bombardment mass spectroscopy; El-MS, electron impact mass spectroscopy.
when GS-NH2EDPA was oxidized with
lead dioxide with concomitant color
change to orange, no compound with the
UV-visible spectrum of GS-EPQDI was
observed; reduction with dithionite
restored part ofGS-NH2EDPA, indicating
that the ring-substituted benzoquinone
diimine had actually been formed.
Therefore, GS-EPQDI was supposed to
contain glutathione not at a ring position
but at the second imino nitrogen. This pre-
sumption was confirmed as mild reduction
ofGS-EPQDI with ascorbate liberated glu-
tathione, which was proved enzymically. In
the reaction of GS-EPQDI with f-
mercaptoethanol, no GS-NH2EDPA was
found, only the ,-mercaptoethanol deriva-
tive. These findings are in agreementwith the
proposed structure.
Considerations ontheMechanisms of
S-ConjugateFormation
The reaction pathways of nitrosoarenes
with aliphatic thiols are known to be dis-
tinctly influenced by their aryl substituents.
EtO&- -NO + GSH
O0_H
OHe
EtO N-SO -SG
"seminercaptal"
+GSH
EtO ON-OH
-0
EsoN=tG ~+°HO <3 EtO-qo-N=SG | EtO
H
~~~~"sulfihuamide"
~~~~~~soGS
+GS9
EtO -N-SG - EtOa- N-SG EtO-Q-N-SG ws EtO(
GS-NH
EtO <)-N-SG;2 > zC FN-SO EtO jN SG ^ EtO
"sufenamide" NH2J
-He
SO
NH2
r,Pt
)2-H ))NH
0D
0D
EIO-~ -N!i
N-SO
EtoHt
- B
+ GS9 GS ~ ~
BtO o N N- SO N-SG -rn-Pt-N-6 N-SQ EtOHN NH2
H Pt-N)(DQ H H D
H ~~ ~ ~ ~ ~~~~
GS-~~~~~~~~~~~~~~NHf2EDPA
0E
0D
Figure 2. Presumed pathways during the reactions of NOPt with GSH.
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Recent results indicate that the initially
formed semimercaptal undergoes N-O
cleavage to give an intermediate sulfen-
amide cation (7,9). The NOPt metabolites
presented here further support that the
sulfenamide cation may play a central role
in NOPt metabolism (compare Figure 2):
a) The formation of N-hydroxy-4-
phenetidine from the semimercaptal was
not observed hitherto (20,21). As generally
deduced by Kazanis and McClelland (7),
the i-donating ethoxy substituent should
favor the N-O cleavage with formation ofa
sulfenamide cation rather than the nucleo-
philic substitution ofGS- at the semimer-
captal sulfur with formation of the
corresponding hydroxylamine. Accordingly,
the semimercaptal that has been detected
with 1-thioglycerol (21) is rapidly con-
verted to the resonance-stabilized sulfen-
amide cation.
b) The formation of appreciable
amounts ofsulfinamide was only observed
when GSH reacted with excess NOPt (9)
(Figure 1B). At excess GSH, however, this
pathway was not followed (Figure 1A),
suggesting that the positive charge is highly
delocalized to the ring carbon atoms
because of the strong i-donating ethoxy
substituent.
c) The formation of GS-NH2Pt at
excess GSH (Figure 1) again indicated the
intermediate occurrence ofa resonance-sta-
bilized sulfenamide cation, which is prone
to nucleophilic ring addition ofGSH. The
resulting 2,N-bis-(glutathione-S-yl)-4-
phenetidine may be rapidly reduced by
GSH or hydrolyzed-as observed with
other sulfenamides-to give GS-NH2Pt.
d) Reaction ofNOPt with excess GSH
mainly led to the sulfenamide which
decomposed to NH2Pt (9). According to
the reaction sequences proposed by Kazanis
and McClelland (7), addition of GS- to
thepara position ofthe sulfenamide cation
and subsequent reduction by further GSH
or hydrolysis would yield the sulfenamide.
Because the para position is thought to
have the major partial charge in the sulfen-
amide cation, the high yields of NH2Pt
would be reasonably explained.
e) The formation ofbicyclic metabolites
supported the consideration that the para
position of the sulfenamide cation may
have the lowest electron density. Obviously
not only GS- but also the less-nucleophilic
NOPt metabolite NH2Pt undergoes ring
addition to this position, delivering the N-
sulfenylquinonediimine GS-EPQDI by
elimination ofEtOH. [This reaction mech-
anism would be consistent with the acid-
catalyzed amination ofp-nitrosophenol
ethers (12), where the initial attack of a
proton at the nitroso oxygen produces a
positive charge at the para position of the
ring.] Accordingly, the reaction of NOPt
with GSH in the presence of authentic
NH2Pt (1:1:1) resulted in immediate pro-
duction of GS-EPQDI at increased yields.
This reaction was shown to occur also with
other arylamines but notwith alkylamines.
f) Reduction ofauthentic GS-EPQDI
with ascorbate resulted in discoloring and
production of a metastable compound-
probably the 2e- reduction product N-(4-
ethoxyphenyl) -N'(glutathione-S-yl)-
phenylenediamine. This compound decom-
posed slowly (faster after acidification) to
give the already known NOPt metabolite
NH2EDPA (11).
g) In incubates of NOPt with > 2.5
excess GSH, the orange color of GS-
EPQDI disappeared after a few minutes.
When authentic GS-EPQDI reacted with
GSH, the ring-substituted GS-NH2EDPA
was formed besides the reduction product
NH2EDPA. The former pathway would be
consistent with a reductive 1.4-Michael
addition of GSH to the quinone diimine
and subsequent hydrolysis or reduction of
the ring substituted bicyclic sulfenamide.
Ferrihemoglobin-formingActivityof
theNOPtMetabolites
The Kiese cycle was found to play only a
minor role during ferrihemoglobin forma-
tion by NOPt (10,22). Because in prelimi-
nary experiments the identified metabolites
Table 5. Ferrihemoglobin formation by some 4-
nitrosophenetol metabolites. Purified human oxyhemo-
globin (3 mM, SH groups blocked) reacted with the
respective 4-nitrosophenetol metabolite (0.1 - 0.3 mM)
at pH 7.4 and 37°C under free access of air (means,
n= 2-6).
NOPt metabolite k2, app. [M-1sec 1]
NH2Pta 0.004 (23)
sulfenamideb 0.04
GS-NH2Ptb 0.1
GS-NH2EDPAb 1.1
GS-EPQDIb 23.8
NH2EDPAd 6.4
'Dissolved in CH3CN. bAqueous solution. CThe reac-
tion kinetics was pseudo first-order after the second
minute, while the reaction proceeded much faster ini-
tially. dDissolved in MeOH.
also were detected in NOPt-exposed
human red cells, we investigated their
activity in producing ferrihemoglobin. As
shown in Table 5, the monocyclic metabo-
lites hardly formed ferrihemoglobin in
solutions ofpurified human hemoglobin.
The bicyclic metabolites GS-EPQDI,
NH2EDPA, and GS-NH2EDPA, however,
were highlyactive, producing many equiva-
lents of ferrihemoglobin by hitherto
unknown mechanisms.
Conclusion
The formation of ring-substituted gluta-
thione S-conjugates during the reactions of
NOPt with glutathione lend further support
to the sulfenamide cation as reactive interme-
diate. This cation obviously reacted not only
with GSH leading to monocyclic metabolites
but also with sufficient nucleophilic aryl-
amines producing various bicyclic metabo-
lites. The latter were shown to be highly
active in producing ferrihemoglobin, once
more indicating that metabolic reactions
with GSH should not be considered oblig-
atory detoxication reactions. Despite its
toxic action in erythrocytes, the stabilized
electrophilic sulfenamide cation may play
an important role in the in vivo toxicity of
t-donor substituted nitrosoarenes.
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